Cellectis SA 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
Cellectis S.A. files an amendment to its 20-F annual report to correct administrative errors in the consents provided by KPMG SA and Ernst & Young et Autres.
NASDAQ
Cellectis S.A. releases its annual report, detailing financial results, strategic plans, and risk factors for the fiscal year ended December 31, 2024.
NASDAQ
Cellectis enters into a subscription agreement with the European Investment Bank (EIB) for the issuance of warrants, linked to tranches of a finance contract.